Jones June E, Nelson E Andrea, Al-Hity Aws
Southport, Merseyside, UK.
Cochrane Database Syst Rev. 2013 Jan 31;2013(1):CD001737. doi: 10.1002/14651858.CD001737.pub4.
Venous leg ulceration is a recurrent, chronic, disabling condition. It affects up to one in 100 people at some time in their lives. Standard treatments are simple dressings and compression bandages or stockings. Sometimes, despite treatment, ulcers remain open for months or years. Sometimes skin grafts are used to stimulate healing. These may be taken, or grown into a dressing, from the patient's own uninjured skin (autografts), or applied as a sheet of bioengineered skin grown from donor cells (allograft). Preserved skin from other animals, such as pigs, has also been used (xenografts).
To assess the effect of skin grafts for treating venous leg ulcers.
For this update we modified the search strategies and conducted searches of The Cochrane Wounds Group Specialised Register (searched 27 July 2012); The Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library 2012, Issue 7); Ovid MEDLINE (2008 to July Week 3 2012); Ovid MEDLINE (In-Process & Other Non-Indexed Citations, July 26, 2012); Ovid EMBASE (2008 to 2012 Week 29); and EBSCO CINAHL (2008 to 26 July 2012). We did not apply date or language restrictions.
Randomised controlled trials (RCTs) of skin grafts in the treatment of venous leg ulcers.
Two review authors independently undertook data extraction and assessment of study quality.
For this update of the review, we identified one new trial, bringing the total to 17 trials (1034 participants) - all of which were generally at moderate or high risk of bias. In 12 trials participants also received compression bandaging.Eleven trials compared a graft with standard care in which no graft was used. Two of these trials (102 participants) compared a dressing with an autograft; three trials (80 participants) compared frozen allografts with dressings, and two trials (45 participants) compared fresh allografts with dressings. Two trials (345 participants) compared tissue-engineered skin (bilayer artificial skin) with a dressing. In two trials (97 participants) a single-layer dermal replacement was compared with standard care.Six trials compared alternative skin grafting techniques. The first trial (92 participants) compared autografts with frozen allograft, a second (51 participants) compared a pinch graft (autograft) with porcine dermis (xenograft), the third (110 participants) compared growth-arrested human keratinocytes and fibroblasts with placebo, the fourth (10 participants) compared an autograft delivered on porcine pads with an autograft delivered on porcine gelatin microbeads, the fifth trial (92 participants) compared a meshed graft with a cultured keratinocyte autograft, and the sixth trial (50 participants) compared a frozen keratinocyte allograft with a lyophilised (freeze-dried) keratinocyte allografts.Significantly more ulcers healed when treated with bilayer artificial skin than with dressings. There was insufficient evidence from the other trials to determine whether other types of skin grafting increased the healing of venous ulcers.
AUTHORS' CONCLUSIONS: Bilayer artificial skin, used in conjunction with compression bandaging, increases venous ulcer healing compared with a simple dressing plus compression. Further research is needed to assess whether other forms of skin grafts increase ulcer healing.
下肢静脉溃疡是一种复发性、慢性、致残性疾病。一生中约有1%的人会在某个时期受到影响。标准治疗方法是使用简单敷料以及加压绷带或弹力袜。有时,尽管进行了治疗,溃疡仍会持续数月或数年不愈合。有时会采用皮肤移植来促进愈合。皮肤移植可以取自患者自身未受伤的皮肤(自体移植),或培养成敷料,也可以使用从供体细胞培养而成的生物工程皮肤片(异体移植)。其他动物如猪的保存皮肤也被用于移植(异种移植)。
评估皮肤移植治疗下肢静脉溃疡的效果。
为了本次更新,我们修改了检索策略,并检索了Cochrane伤口小组专业注册库(检索日期为2012年7月27日);Cochrane对照试验中心注册库(CENTRAL)(Cochrane图书馆2012年第7期);Ovid MEDLINE(2008年至2012年第3周);Ovid MEDLINE(在研及其他未索引文献,2012年7月26日);Ovid EMBASE(2008年至2012年第29周);以及EBSCO CINAHL(2008年至2012年7月26日)。我们未设置日期或语言限制。
关于皮肤移植治疗下肢静脉溃疡的随机对照试验(RCT)。
两位综述作者独立进行数据提取和研究质量评估。
在本次综述更新中,我们识别出一项新试验,使试验总数达到17项(1034名参与者)——所有试验总体上都存在中度或高度偏倚风险。在12项试验中,参与者还接受了加压绷带治疗。11项试验将皮肤移植与未使用移植的标准治疗进行了比较。其中两项试验(102名参与者)将一种敷料与自体移植进行了比较;三项试验(80名参与者)将冷冻异体移植与敷料进行了比较,两项试验(45名参与者)将新鲜异体移植与敷料进行了比较。两项试验(345名参与者)将组织工程皮肤(双层人工皮肤)与一种敷料进行了比较。在两项试验(97名参与者)中,将单层真皮替代物与标准治疗进行了比较。六项试验比较了不同的皮肤移植技术。第一项试验(92名参与者)将自体移植与冷冻异体移植进行了比较,第二项试验(51名参与者)将点状移植(自体移植)与猪真皮(异种移植)进行了比较,第三项试验(110名参与者)将生长停滞的人角质形成细胞和成纤维细胞与安慰剂进行了比较,第四项试验(10名参与者)将猪垫上的自体移植与猪明胶微珠上的自体移植进行了比较,第五项试验(92名参与者)将网状移植与培养的角质形成细胞自体移植进行了比较,第六项试验(50名参与者)将冷冻角质形成细胞异体移植与冻干角质形成细胞异体移植进行了比较。与使用敷料相比,使用双层人工皮肤治疗时溃疡愈合的比例显著更高。其他试验提供的证据不足,无法确定其他类型的皮肤移植是否能促进下肢静脉溃疡的愈合。
与单纯敷料加加压治疗相比,双层人工皮肤联合加压绷带可促进下肢静脉溃疡的愈合。需要进一步研究以评估其他形式的皮肤移植是否能促进溃疡愈合。